Default company panoramic image
Ff2963e5 dac5 4621 b803 e937d1cfa301

RhinoCyte, Inc.

RhinoCyte™, Inc. is a biotechnology company founded in 2005. RhinoCyte will be a leader in the advancement of cell based therapies by providing innovative auto

  • Stage Concept Only
  • Industry Biotechnology
  • Location Louisville, KY, USA
  • Currency USD
  • Employees 8
  • Website

Company Summary

RhinoCyte’s lead product is an autologous progenitor cellular replacement or enhancement therapy termed RhinoCytes for Spinal Cord Injury. The product promotes recovery of cell damage resulting from degenerative neurological diseases or traumatic injury. SCI affects more than 365,000 patients in the United States, with 13,000 new cases annually. The annual total costs for SCI exceed $26 Billion.
RhinoCyte’s technology will also benefit patient


  • Default avatar
    Steve Gailar
    Acting President and CEO

    Steve Gailar spent 30 years as a manager of, and investor in, various life sciences businesses. During fourteen years at Eli Lilly and Company he held various management positions in finance, sales and marketing, as well as establishing the initial Pharmaceutical Strategic Planning component for the company which determined future competencies, investments and acquisitions. Steve spent three years in the San Francisco Bay Area in senior manageme

  • Default avatar
    Teresa Leezer
    Acting COO

    Teresa Leezer brings over twenty years of executive management experience from Hoffman-LaRoche, Merck Labs and Bristol Myers Squibb respectively. Her expertise includes the management of business units, portfolios and products in every phase of the life cycle - from pre-clinical, to launch, growth and maturity. Her Fortune 100 pharmaceutical experience in sales, marketing and management spans the institutional, physician and over the counter mark

  • Default avatar
    Fred Roisen, Ph.D.
    Founder and CSO

    Dr. Roisen earned a Ph.D. in the field of cellular physiology from Princeton University in 1969. He rose rapidly through the professorial ranks to Professor and Acting Chair of the Department of Anatomy at Rutgers Medical School. Since 1986, Dr. Roisen has been a Professor and Chair of the Department of Anatomical Sciences and Neurobiology at the University of Louisville.

    He has studied the structure-function relationships in developmental

  • Default avatar
    Chengliang Lu, M.D.
    Senior Scientist

    Dr. Lu is a Research Manager in the Department of Anatomical Sciences and Neurobiology at the University of Louisville. He received his M.D. from the Shanghai Second Medical University in 1968 and his Masters of Science from the Nanjing Medical University in 1983. He has worked with Dr. Roisen for more than a decade developing in vitro and in vivo models for the assay of neural progenitors. He has published over 20 papers and has presented over


  • Default avatar
    William G. Strench, Frost Brown Todd
    Default avatar
    Laura DeSalvo, DeSalvo & Co.